Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Atul Kumar
Observed name:
Atul Kumar Rai
Institutions:
Motilal Nehru National Institute of Technology,
Institute of Medical Sciences,
Banaras Hindu University
Observed institutions:
Motilal Nehru National Institute of Technology,
University of New Mexico,
Central University of Kerala,
UNM Comprehensive Cancer Center,
Institute of Medical Sciences,
Dibrugarh University,
Central University of Rajasthan,
Banaras Hindu University,
Stanford University
show all 9
ORCID:
0000-0001-8708-6203
Observed ORCID:
0000-0001-8708-6203
OpenAlex ID:
A5100746322
SWOG S1929: Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer (ES-SCLC).
2023
·
Nagla Fawzy Abdel Karim
, Jieling Miao
, et al.
·
Journal of Clinical Oncology
·
36
An effective fuzzy based segmentation and twin attention based convolutional gated recurrent network for skin cancer detection
2023
·
Atul Kumar Rai
, Shivani Agarwal
, et al.
·
Multimedia Tools and Applications
·
18
A pharmacognostic approach for mitigating pancreatic cancer: emphasis on herbal extracts and phytoconstituents
2021
·
Shruti Gupta
, Atul Kumar
, et al.
·
Future Journal of Pharmaceutical Sciences
·
11
PDF
Drug-excipient(s) interactions and compatibility study: A Review
2015
·
Md. Zaki Ahmad
, Vijay Kumar
, et al.
·
Journal of Pharmacy Research
·
11
Role of Ayurveda in Public Health: A Critical Review
2022
·
Manglakant Jha
, Mithilesh Kumar Sah
, et al.
·
International Journal of Research in AYUSH and Pharmaceutical Sciences
·
8
PDF
Unfolding antifungals: as a new foe to pancreatic ductal adenocarcinoma—a mini-review
2021
·
Shruti Gupta
, Atul Kumar
, et al.
·
Molecular Biology Reports
·
6
Convolutional Neural Network Based Technique for Efficient Waste Classification
2024
·
Soumadeep Sarkar
, Saheb Sarkar
, et al.
·
IEEE International Conference on Computer Vision and Machine Intelligence (CVMI)
·
5
Outcomes of responders to PD-1/PD-L1 inhibitors who discontinue therapy after sustained disease control
2023
·
Harsh Sharma
, Krishna R. Moturi
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
4
PDF
Proteome profiling of human lung epithelial cells unveils distinct patterns of protein expression in response to SARS-CoV-2 ORF3a
2025
·
Apoorva
, Astha Shukla
, et al.
·
The Microbe
·
3
Real-time Posture Correction System in sitting using Deep Learning Techniques
2025
·
Rupesh Kumar Dewang
, Abid Ali
, et al.
·
IEEE International Conference on Communication Systems and Network Technologies (CSNT)
·
2
Comparing the Performance of Supervised, Unsupervised and Hybrid Learning on Medical Insurance Fraud Detection
2025
·
Saloni Kumari
, Neelanshi Jaiswal
, et al.
·
Communications in computer and information science
·
1
Stock Price Prediction using CABC Trained Neural Network
2024
·
Atul Kumar
, Keerti Singh
, et al.
·
International Conference on Computer, Electronics & Electrical Engineering & their Applications (IC2E3)
·
1
Retraction Note: Melastoma malabathricum Linn attenuates complete freund’s adjuvant-induced chronic inflammation in Wistar rats via inflammation response
2022
·
Vikas Kumar
, Prakash Chandra Bhatt
, et al.
·
BMC Complementary Medicine and Therapies
·
1
PDF
Outcomes of responders to PD-1/PD-L1 inhibitors who discontinue therapy after sustained disease control.
2022
·
Harsh Sharma
, Krishna Rekha Moturi
, et al.
·
Journal of Clinical Oncology
·
1
Abnormal Endometrium and Hysteroscopy
2020
·
Alka Kumar
, Atul Kumar
·
Springer eBooks
P3-107: Safety of gemcitabine and carboplatin plus bevacizumab for advanced stage non–small cell lung cancer (NSCLC): pooled preliminary safety data from two ongoing studies
2007
·
Michael J. Kraut
, Atul Kumar
, et al.
·
Journal of Thoracic Oncology
Show more works
View as search
Works count:
16
Citation count:
108
H-index:
6
I10-index:
4
Year
Topic
Type